Shinji Nakamichi

Also affiliated with National Cancer Institute, Center for Cancer Research, Nippon Medical School

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer”.

SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer

Carcinogenesis(2025)10.1093/carcin/bgaf082

N/A

0DataRank · unranked

1 citations

Natalia von Muhlinen, Leo Yamada, Jilian R. Melamed, Tyler E. Papp, Hamideh Parhiz +4 more

SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.05.652234

N/A

0DataRank · unranked

2 citations

Natalia von Muhlinen, Leo Yamada, Jilian R. Melamed, Tyler E. Papp, Hamideh Parhiz +4 more